A novel HIV-based lentiviral vector can introduce a gene to pancreatic tumor cells that makes them more sensitive to the chemotherapeutic drug gemcitabine, without integrating into cellular DNA.
Source: HIV/AIDS news from Medical News Today
Monat: Februar 2016
HIV in Rhode Island: Newly diagnosed men often 'hooked up' online
More than 60 percent of Rhode Island men who have sex with men (MSM) diagnosed with HIV in 2013 reported meeting sexual partners online in the preceding year, according to a study published in the…
Source: HIV/AIDS news from Medical News Today
Antidepressant may improve cognitive symptoms in people with HIV
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in…
Source: HIV/AIDS news from Medical News Today
Maraviroc-containing regimens safe, tolerable when taken for HIV prevention
Maraviroc, an oral drug used to treat HIV infection, is safe and well-tolerated when taken daily as pre-exposure prophylaxis (PrEP) to prevent HIV infection by HIV-uninfected men who have sex with…
Source: HIV/AIDS news from Medical News Today
Client-centered care coordination attains high uptake for pre-exposure prophylaxis for prevention of HIV infection among US BMSM
Investigators from the HIV Prevention Trials Network (HPTN) have announced key results from the HPTN 073 Study at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston…
Source: HIV/AIDS news from Medical News Today
International study finds rectal microbicide gel safe when used daily and with sex
Participants as adherent to using gel with sex as taking a daily pill for HIV prevention.
Source: HIV/AIDS news from Medical News Today
Experimental Ebola vaccines well tolerated, immunogenic in phase 2 study
Two investigational vaccines designed to protect against Ebola virus disease were well-tolerated and induced an immune response among 1,000 vaccinated participants in the Phase 2 randomized…
Source: HIV/AIDS news from Medical News Today
Zolodrenic acid can prevent early bone loss in HIV patients on antiretroviral therapy
A single dose of the drug zoledronic acid was found to inhibit the bone loss that is common in HIV-infected patients and that is increased during the first two years of treatment with…
Source: HIV/AIDS news from Medical News Today
Option B+ to prevent maternal transmission of HIV shows rise in women initiating therapy
The first findings from a study in the Kingdom of Swaziland on a new approach to reduce mother to child transmission of HIV were presented at the annual Conference on Retroviruses and Opportunistic…
Source: HIV/AIDS news from Medical News Today
Vaginal ring reduces risk of HIV by up to 61%
In Sub-Saharan Africa, vaginal rings releasing dapivirine safely reduced the risk of HIV by 61% in women over 25 years who used them consistently.
Source: HIV/AIDS news from Medical News Today